Recently, a Chinese research team has successfully developed a new surgical robot with independent intellectual property rights, marking a significant breakthrough in China’s high-end medical equipment sector. The robot features high-precision robotic arms, a multi-degree-of-freedom flexible control system, and an AI-assisted decision-making module, enabling highly accurate operations in minimally invasive surgeries. Compared to traditional surgical methods, this system significantly reduces intraoperative bleeding, shortens postoperative recovery time, and alleviates surgeon fatigue. The development team—comprising researchers from leading Chinese universities and medical institutions—spent five years overcoming key technical challenges, including miniaturized sensor integration, real-time image processing, and human-robot collaborative control. The robot has completed animal trials and is now preparing for clinical trials. It is expected to be widely used in urology, gynecology, cardiothoracic surgery, and other specialties. This achievement not only enhances China’s capacity for independent innovation in advanced medical devices but also offers a Chinese solution to the global advancement of intelligent healthcare.
近日，中国科研团队成功研发出一款具有自主知识产权的新型手术机器人，标志着我国在高端医疗装备领域取得重要突破。该机器人采用高精度机械臂、多自由度灵活控制系统和人工智能辅助决策模块，能够实现微创手术中的精准操作。与传统手术方式相比，该系统可显著减少术中出血、缩短术后恢复时间，并降低医生操作疲劳。研发团队来自国内顶尖高校与医疗机构，历时五年攻克了包括微型传感器集成、实时图像处理和人机协同控制在内的多项关键技术。目前，该机器人已完成动物实验，进入临床试验准备阶段，未来有望广泛应用于泌尿外科、妇科、心胸外科等多个领域。这一成果不仅提升了我国高端医疗器械的自主创新水平，也为全球智能医疗发展贡献了中国方案。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/17851.html